Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 1,479 | 982 | 1,247 | 1,149 | 1,373 |
| Gross Profit | 1,479 | 982 | 1,247 | 1,149 | 1,373 |
| Operating Expenses | 8,199 | 7,313 | 6,790 | 7,450 | 6,868 |
| Operating Income | -6,720 | -6,331 | -5,543 | -6,301 | -5,495 |
| Other Income | 88 | 84 | 60 | 63 | 65 |
| Pre-tax Income | -6,632 | -6,247 | -5,483 | -6,238 | -5,430 |
| Net Income Continuous | -6,632 | -6,247 | -5,483 | -6,238 | -5,430 |
| Net Income | $-6,632 | $-6,247 | $-5,483 | $-6,238 | $-5,430 |
| EPS Basic Total Ops | -11.75 | -11.75 | 145.25 | -11.75 | -11.50 |
| EPS Basic Continuous Ops | -11.75 | -11.68 | 145.25 | -11.70 | -11.53 |
| EPS Diluted Total Ops | -11.75 | -11.75 | 145.25 | -11.75 | -11.50 |
| EPS Diluted Continuous Ops | -11.75 | -11.68 | 145.25 | -11.70 | -11.53 |
| EBITDA(a) | $-6,627 | $-6,230 | $-5,457 | $-6,230 | $-5,450 |